Story perspectives

US Plasma Exchange Market Surges Amid Autoimmune Disease Rise

11/5/2025

24 4

Summary

Story summary

The US Therapeutic Plasma Exchange market is growing significantly due to rising autoimmune diseases and technology advances.
Key segments include neurological disorders like Guillain-Barré syndrome.
Point-of-care systems enable smaller facilities to offer these treatments.
NHS England invested USD 1.5 million in Spectra Optia systems to boost capacity.
Opportunities exist to expand clinical applications and improve cost-effectiveness despite high equipment costs and rural workforce shortages.

1 of 1

Story summary

The US Therapeutic Plasma Exchange market is growing significantly due to rising autoimmune diseases and technology advances.
Key segments include neurological disorders like Guillain-Barré syndrome.
Point-of-care systems enable smaller facilities to offer these treatments.
NHS England invested USD 1.5 million in Spectra Optia systems to boost capacity.
Opportunities exist to expand clinical applications and improve cost-effectiveness despite high equipment costs and rural workforce shortages.